Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sparano

Showing results (11-20 of 293) with videos related to

Pageof 30
Sort By:
Expert Opinion on Pharmacotherapy|November 25, 2017
New agents for the management of resistant metastatic breast cancerJesus Anampa, Joseph A Sparano
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2008
Development of the 21-gene assay and its application in clinical practice and clinical trialsJoseph A Sparano, Soonmyung Paik
Current Treatment Options in Oncology|November 20, 2012
How do I treat inflammatory breast cancer?Della Makower, Joseph A Sparano
Clinical Breast Cancer|March 15, 2003
Inhibiting Ras signaling in the therapy of breast cancerTianhong Li, Joseph A Sparano
Journal of the American Chemical Society|October 27, 2005
A strategy for the development of small-molecule-based sensors that strongly fluoresce when bound to a specific RNABrian A Sparano, Kazunori Koide
Current Breast Cancer Reports|February 27, 2013
Chemotherapy in Patients with Anthracycline- and Taxane-Pretreated Metastatic Breast Cancer: An OverviewEleni Andreopoulou, Joseph A Sparano
Journal of the American Chemical Society|March 28, 2007
Fluorescent sensors for specific RNA: a general paradigm using chemistry and combinatorial biologyBrian A Sparano, Kazunori Koide
Seminars in Oncology|September 12, 2001
Liposomal anthracyclines for breast cancerJ A Sparano, E P Winer
The AIDS Reader|December 3, 2003
Metastatic carcinoma: an unusual cause of focal brain lesions in HIV infectionAnu G Gaba, Joseph A Sparano
Clinical Advances in Hematology & Oncology : H&O|October 15, 2005
Human immunodeficiency virus-associated lymphomaSamir Parekh, Howard Ratech, Joseph A Sparano
Pageof 30

Showing results (11-20 of 293) with videos related to

Sort By:
Pageof 30
Expert Opinion on Pharmacotherapy|November 25, 2017
New agents for the management of resistant metastatic breast cancerJesus Anampa, Joseph A Sparano
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2008
Development of the 21-gene assay and its application in clinical practice and clinical trialsJoseph A Sparano, Soonmyung Paik
Current Treatment Options in Oncology|November 20, 2012
How do I treat inflammatory breast cancer?Della Makower, Joseph A Sparano
Clinical Breast Cancer|March 15, 2003
Inhibiting Ras signaling in the therapy of breast cancerTianhong Li, Joseph A Sparano
Journal of the American Chemical Society|October 27, 2005
A strategy for the development of small-molecule-based sensors that strongly fluoresce when bound to a specific RNABrian A Sparano, Kazunori Koide
Current Breast Cancer Reports|February 27, 2013
Chemotherapy in Patients with Anthracycline- and Taxane-Pretreated Metastatic Breast Cancer: An OverviewEleni Andreopoulou, Joseph A Sparano
Journal of the American Chemical Society|March 28, 2007
Fluorescent sensors for specific RNA: a general paradigm using chemistry and combinatorial biologyBrian A Sparano, Kazunori Koide
Seminars in Oncology|September 12, 2001
Liposomal anthracyclines for breast cancerJ A Sparano, E P Winer
The AIDS Reader|December 3, 2003
Metastatic carcinoma: an unusual cause of focal brain lesions in HIV infectionAnu G Gaba, Joseph A Sparano
Clinical Advances in Hematology & Oncology : H&O|October 15, 2005
Human immunodeficiency virus-associated lymphomaSamir Parekh, Howard Ratech, Joseph A Sparano
Pageof 30